MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators
Abstract A severe lack of early diagnosis coupled with resistance to most available therapeutic options renders pancreatic cancer as a major clinical concern. The limited efficacy of current treatments necessitates the development of novel therapeutic strategies that are based on an understanding of...
Main Authors: | Afra Z. Daoud, Eoghan J. Mulholland, Grace Cole, Helen O. McCarthy |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-6284-y |
Similar Items
-
Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
by: Natalia Gablo, et al.
Published: (2020-07-01) -
The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
by: Ren L, et al.
Published: (2018-01-01) -
Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
by: Liao X, et al.
Published: (2018-08-01) -
MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential
by: Manmeet Rawat, et al.
Published: (2019-09-01) -
A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma
by: Yu Y, et al.
Published: (2018-06-01)